4527 N Stock Overview
Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rohto Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥320.18 |
| 52 Week High | JP¥320.18 |
| 52 Week Low | JP¥320.18 |
| Beta | -0.094 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -2.43% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4527 N | MX Personal Products | MX Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | n/a | 0% | 0% |
Return vs Industry: Insufficient data to determine how 4527 N performed against the MX Personal Products industry.
Return vs Market: Insufficient data to determine how 4527 N performed against the MX Market.
Price Volatility
| 4527 N volatility | |
|---|---|
| 4527 N Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in MX Market | 0% |
| 10% least volatile stocks in MX Market | 0% |
Stable Share Price: 4527 N has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 4527 N's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1899 | 7,176 | Yamada Kunio | www.rohto.co.jp |
Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams.
Rohto Pharmaceutical Co.,Ltd. Fundamentals Summary
| 4527 N fundamental statistics | |
|---|---|
| Market cap | Mex$77.64b |
| Earnings (TTM) | Mex$3.43b |
| Revenue (TTM) | Mex$29.28b |
22.6x
P/E Ratio2.7x
P/S RatioIs 4527 N overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4527 N income statement (TTM) | |
|---|---|
| Revenue | JP¥263.56b |
| Cost of Revenue | JP¥110.16b |
| Gross Profit | JP¥153.41b |
| Other Expenses | JP¥122.51b |
| Earnings | JP¥30.90b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 135.43 |
| Gross Margin | 58.20% |
| Net Profit Margin | 11.72% |
| Debt/Equity Ratio | 3.9% |
How did 4527 N perform over the long term?
See historical performance and comparison